[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Celltrioninc Celltrion Celltrion posts on X about future of, has been, regulatory the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::1405775970217324545/interactions)  - X Week XXX -XX% - X Month XXX +44% - X Months XXXXX +25% - X Year XXXXX -XX% ### Mentions: X [#](/creator/twitter::1405775970217324545/posts_active)  - X Week X -XX% - X Month XX +45% - X Months XX +63% - X Year XX +342% ### Followers: XXX [#](/creator/twitter::1405775970217324545/followers)  - X Week XXX no change - X Month XXX +2.10% - X Months XXX +13% - X Year XXX +31% ### CreatorRank: undefined [#](/creator/twitter::1405775970217324545/influencer_rank)  ### Social Influence [#](/creator/twitter::1405775970217324545/influence) --- **Social topic influence** [future of](/topic/future-of) 3.13%, [has been](/topic/has-been) 3.13%, [regulatory](/topic/regulatory) XXXX% **Top accounts mentioned or mentioned by** [@eucommission](/creator/undefined) [@thepharmaletter](/creator/undefined) [@vegas_whoa](/creator/undefined) [@prometheuslab](/creator/undefined) [@dikajob](/creator/undefined) [@ej23ny](/creator/undefined) [@njbiz](/creator/undefined) [@fatneckchillin](/creator/undefined) [@hop_con_rx](/creator/undefined) [@invgurind](/creator/undefined) [@agwmeeting](/creator/undefined) [@arthritis_arc](/creator/undefined) [@1deadmanx](/creator/undefined) [@boogeymantradez](/creator/undefined) [@etpharma](/creator/undefined) [@greatstockpicks](/creator/undefined) [@biopharmintl](/creator/undefined) [@healioderm](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1405775970217324545/posts) --- Top posts by engagements in the last XX hours "At UEG Week 2025 Celltrion presented real-world data on subcutaneous infliximab during a Meet-the-Expert session. Celltrion remains committed to advancing innovative biologics improving access and supporting sustainable healthcare worldwide. View the press release here:" [X Link](https://x.com/Celltrioninc/status/1975145585310306480) [@Celltrioninc](/creator/x/Celltrioninc) 2025-10-06T10:26Z XXX followers, XX engagements "Celltrion is thrilled to participate in #UEGWeek 2025 the premier event in European #gastroenterology From October XX at Messe Berlin visit booth number XXXX to explore our robust #IBD solutions. 🌍🔍 Talk with our experts dive into detailed insights and discover how Celltrion is redefining personalized care for digestive diseases" [X Link](https://x.com/Celltrioninc/status/1971385401018610164) [@Celltrioninc](/creator/x/Celltrioninc) 2025-09-26T01:24Z XXX followers, XX engagements "Celltrion is now participating in UEGW 2025 Discover our latest data and insights in the field of gastroenterology by visiting our booth. We look forward to meeting you in person at the congress. Stop by and be part of the conversation shaping the future of gastroenterology. #UEGW2025 #Celltrion #BuiltonTrustDrivingInnovation #Gastroenterology" [X Link](https://x.com/Celltrioninc/status/1974812274964803896) [@Celltrioninc](/creator/x/Celltrioninc) 2025-10-05T12:21Z XXX followers, XXX engagements "Were proud to announce that Celltrion has been selected as a finalist for the 2025 Global Generics & Biosimilars Awards This recognition in the Biosimilar Initiative of the Year category highlights Celltrions leadership in advancing access to high-quality biologics through innovation reliability and sustainable growth. By achieving major regulatory milestones and expanding into new therapeutic areas Celltrion continues to set new standards for excellence in the global biosimilar industry. We remain dedicated to improving treatment access and patient outcomes worldwide through our fully" [X Link](https://x.com/Celltrioninc/status/1978005586676707727) [@Celltrioninc](/creator/x/Celltrioninc) 2025-10-14T07:50Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Celltrion posts on X about future of, has been, regulatory the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours.
Social topic influence future of 3.13%, has been 3.13%, regulatory XXXX%
Top accounts mentioned or mentioned by @eucommission @thepharmaletter @vegas_whoa @prometheuslab @dikajob @ej23ny @njbiz @fatneckchillin @hop_con_rx @invgurind @agwmeeting @arthritis_arc @1deadmanx @boogeymantradez @etpharma @greatstockpicks @biopharmintl @healioderm
Top posts by engagements in the last XX hours
"At UEG Week 2025 Celltrion presented real-world data on subcutaneous infliximab during a Meet-the-Expert session. Celltrion remains committed to advancing innovative biologics improving access and supporting sustainable healthcare worldwide. View the press release here:"
X Link @Celltrioninc 2025-10-06T10:26Z XXX followers, XX engagements
"Celltrion is thrilled to participate in #UEGWeek 2025 the premier event in European #gastroenterology From October XX at Messe Berlin visit booth number XXXX to explore our robust #IBD solutions. 🌍🔍 Talk with our experts dive into detailed insights and discover how Celltrion is redefining personalized care for digestive diseases"
X Link @Celltrioninc 2025-09-26T01:24Z XXX followers, XX engagements
"Celltrion is now participating in UEGW 2025 Discover our latest data and insights in the field of gastroenterology by visiting our booth. We look forward to meeting you in person at the congress. Stop by and be part of the conversation shaping the future of gastroenterology. #UEGW2025 #Celltrion #BuiltonTrustDrivingInnovation #Gastroenterology"
X Link @Celltrioninc 2025-10-05T12:21Z XXX followers, XXX engagements
"Were proud to announce that Celltrion has been selected as a finalist for the 2025 Global Generics & Biosimilars Awards This recognition in the Biosimilar Initiative of the Year category highlights Celltrions leadership in advancing access to high-quality biologics through innovation reliability and sustainable growth. By achieving major regulatory milestones and expanding into new therapeutic areas Celltrion continues to set new standards for excellence in the global biosimilar industry. We remain dedicated to improving treatment access and patient outcomes worldwide through our fully"
X Link @Celltrioninc 2025-10-14T07:50Z XXX followers, XX engagements
/creator/twitter::Celltrioninc